Prediction of inhibitory constants of compounds against SARS-CoV 3CLpro enzyme with 2D-QSAR model
Author:
Open Access
- 1 July 2021
- journal article
- research article
- Published by Springer Nature in Journal of Saudi Chemical Society
- Vol. 25 (7) , 101262
Abstract
Developing broad-spectrum anti-coronavirus drugs is greatly important, since the novel SARS-CoV-2 has rapidly become a threat to the public health and economy worldwide. SARS-CoV 3-chymotrypsin-like protease (3CLpro), as highly conserved in betacoronavirus, is a viable target for anti-SARS drugs. A quantitative structure–activity relationship (QSAR) for inhibitory constants (pKi) of 89 compounds against SARS-CoV 3CLpro enzyme was developed by using support vector machine (SVM) and genetic algorithm. The optimal SVM model (C = 90.2339 and γ = 1.19826 × 10−5) based on six molecular descriptors has determination coefficients of 0.839 for the training set (65 compounds) and 0.747 for test set (24 compounds), and rms errors of 0.435 and 0.525, respectively. These results are accurate and acceptable compared with that in other models reported, although our SVM model deals with more samples in the dada set. The SVM model could be beneficial for search of novel 3CLpro enzyme inhibitors against SARS-CoV.Keywords
This publication has 19 references indexed in Scilit:
- Multiple quantitative structure-activity relationships (QSARs) analysis for orally active trypanocidal N-myristoyltransferase inhibitorsJournal of Molecular Structure, 2019
- Prediction of the onset temperature of decomposition of lubricant additivesJournal of Thermal Analysis and Calorimetry, 2017
- Prediction of the maximum nonseizure load of lubricant additivesJournal of Theoretical and Computational Chemistry, 2017
- QSAR analysis for 6-arylpyrazine-2-carboxamides as Trypanosoma brucei inhibitorsSAR and QSAR in Environmental Research, 2017
- Optimization of antiproliferative activity of substituted phenyl 4-(2-oxoimidazolidin-1-yl) benzenesulfonates: QSAR and CoMFA analysesEuropean Journal of Pharmaceutical Sciences, 2015
- Tautomerism and multiple modelling enhance the efficacy of QSAR: antimalarial activity of phosphoramidate and phosphorothioamidate analogues of amiprophos methylMedicinal Chemistry Research, 2014
- Development of potent dipeptide-type SARS-CoV 3CL protease inhibitors with novel P3 scaffolds: Design, synthesis, biological evaluation, and docking studiesEuropean Journal of Medicinal Chemistry, 2013
- Design, synthesis, and biological evaluation of novel dipeptide-type SARS-CoV 3CL protease inhibitors: Structure–activity relationship studyEuropean Journal of Medicinal Chemistry, 2013
- Design and synthesis of new tripeptide-type SARS-CoV 3CL protease inhibitors containing an electrophilic arylketone moietyBioorganic & Medicinal Chemistry, 2013
- DFT-based quantum theory QSPR studies of molar heat capacity and molar polarization of vinyl polymersChemical Papers, 2008